| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.00052 | 1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.045 | 0.5 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.046 | 0.5 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.056 | 0.4 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.067 | 0.2 |